Warning Letter Roundup & Recap – June 28, 2016
This article was originally published in The Gray Sheet
Marketer of the HemaSpot dried blood spot collection device cited for premarket reg violations; QS and premarket reg citations noted at maker of OTC iontophoresis devices; and more. FDA released warning letters to three device companies this week.
Register for our free email digests: